regarding infant rotavirus vaccination after in utero exposure to either TNFi or rituximab should be discussed with the pregnant RMD patient prior to delivery. Specifically, the pregnant patient should be educated as to the fact that medications that cross the placenta may affect vaccination schedules for their infants. A copy of the current vaccine guideline summary ( https:// www.rheumatology.org/Portals/0/Files/Vaccinations-Guidance- Whether to give multiple vaccinations to patients with RMD